Works matching IS 00778923 AND DT 2000 AND VI 922 AND IP 1
Results: 47
Improvement of Therapeutic Index of Low-Dose Topotecan Delivered per os.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 330, doi. 10.1111/j.1749-6632.2000.tb07057.x
- By:
- Publication type:
- Article
The Homocamptothecin, BN 80927, Is a Potent Topoisomerase I Poison and Topoisomerase II Catalytic Inhibitor.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 301, doi. 10.1111/j.1749-6632.2000.tb07048.x
- By:
- Publication type:
- Article
Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Malignancies in the Lungs.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 352, doi. 10.1111/j.1749-6632.2000.tb07063.x
- By:
- Publication type:
- Article
Camptothecin Dose, Schedule, and Timing of Administration for Clinical Radiation Sensitization.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 334, doi. 10.1111/j.1749-6632.2000.tb07058.x
- By:
- Publication type:
- Article
DX-8951f: Summary of Phase I Clinical Trials.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 260, doi. 10.1111/j.1749-6632.2000.tb07044.x
- By:
- Publication type:
- Article
Phase I Study of 9-Nitro-20(S)-Camptothecin in Combination with Cisplatin for Patients with Advanced Malignancies.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 345, doi. 10.1111/j.1749-6632.2000.tb07061.x
- By:
- Publication type:
- Article
In Vitro Antitumor Activity of 9-Nitro-Camptothecin as a Single Agent and in Combination with other Antitumor Drugs.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 293, doi. 10.1111/j.1749-6632.2000.tb07046.x
- By:
- Publication type:
- Article
The Clinical Development of 9-Aminocamptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 224, doi. 10.1111/j.1749-6632.2000.tb07041.x
- By:
- Publication type:
- Article
A Spectrophotometric Study of the pH-Dependent and DNA Binding Properties of Topotecan.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 309, doi. 10.1111/j.1749-6632.2000.tb07051.x
- By:
- Publication type:
- Article
Phase II Study of Intravenous DX-8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 349, doi. 10.1111/j.1749-6632.2000.tb07062.x
- By:
- Publication type:
- Article
Mechanisms of Resistance to Camptothecins.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 46, doi. 10.1111/j.1749-6632.2000.tb07024.x
- By:
- Publication type:
- Article
Conjugation of Camptothecins to Poly-(l-Glutamic Acid).
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 136, doi. 10.1111/j.1749-6632.2000.tb07032.x
- By:
- Publication type:
- Article
Rapid Chromatin Reorganization Induced by Topoisomerase I-Mediated DNA Damage.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 340, doi. 10.1111/j.1749-6632.2000.tb07059.x
- By:
- Publication type:
- Article
Inhibition of DNA Replication in Camptothecin-Treated Cells Is Regulated by Protein Kinases.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 355, doi. 10.1111/j.1749-6632.2000.tb07064.x
- By:
- Publication type:
- Article
Action of Topoisomerase Targeting Drugs on Non-Hodgkin's Lymphoma and Leukemia: Correlation of Clinical and Cell Culture Studies.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 326, doi. 10.1111/j.1749-6632.2000.tb07056.x
- By:
- Publication type:
- Article
Preclinical and Clinical Trials of Topoisomerase Inhibitors.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 92, doi. 10.1111/j.1749-6632.2000.tb07028.x
- By:
- Publication type:
- Article
Cellular and Molecular Responses to Topoisomerase I Poisons: Exploiting Synergy for Improved Radiotherapy.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 274, doi. 10.1111/j.1749-6632.2000.tb07045.x
- By:
- Publication type:
- Article
Metabolism of CPT-11: Impact on Activity.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 205, doi. 10.1111/j.1749-6632.2000.tb07039.x
- By:
- Publication type:
- Article
Pharmacology of Camptothecin Esters.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 216, doi. 10.1111/j.1749-6632.2000.tb07040.x
- By:
- Publication type:
- Article
Structure-Based Analysis of the Effects of Camptothecin on the Activities of Human Topoisomerase I.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 56, doi. 10.1111/j.1749-6632.2000.tb07025.x
- By:
- Publication type:
- Article
Modified Lactone/Carboxylate Salt Equilibria in Vivo by Liposomal Delivery of 9-Nitro-Camptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 164, doi. 10.1111/j.1749-6632.2000.tb07034.x
- By:
- Publication type:
- Article
Dependence of Anticancer Activity of Camptothecins on Maintaining Their Lactone Function.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 27, doi. 10.1111/j.1749-6632.2000.tb07022.x
- By:
- Publication type:
- Article
New Analogues of Camptothecins: Activity and Resistance.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 175, doi. 10.1111/j.1749-6632.2000.tb07035.x
- By:
- Publication type:
- Article
Mechanism of Action of Camptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 1, doi. 10.1111/j.1749-6632.2000.tb07020.x
- By:
- Publication type:
- Article
The Dual Topoisomerase Inhibitor, BN 80927, Is Highly Potent against Cell Proliferation and Tumor Growth.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 303, doi. 10.1111/j.1749-6632.2000.tb07049.x
- By:
- Publication type:
- Article
NF-κB Activation in Topoisomerase I Inhibitor-Induced Apoptotic Cell Death in Human Non-Small Cell Lung Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 343, doi. 10.1111/j.1749-6632.2000.tb07060.x
- By:
- Publication type:
- Article
Kinetics of in Vitro Hydrolysis of Homocamptothecins As Measured by Fluorescence.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 314, doi. 10.1111/j.1749-6632.2000.tb07052.x
- By:
- Publication type:
- Article
Molecular and Biological Determinants of the Cytotoxic Actions of Camptothecins: Perspective for the Development of New Topoisomerase I Inhibitors.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 11, doi. 10.1111/j.1749-6632.2000.tb07021.x
- By:
- Publication type:
- Article
The Cascade Radical Annulation Approach to New Analogues of Camptothecins: Combinatorial Synthesis of Silatecans and Homosilatecans.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 112, doi. 10.1111/j.1749-6632.2000.tb07030.x
- By:
- Publication type:
- Article
Alternative Administration of Camptothecin Analogues.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 237, doi. 10.1111/j.1749-6632.2000.tb07042.x
- By:
- Publication type:
- Article
Intraperitoneal Topoisomerase-I Inhibitors: Preliminary Findings with 9-Aminocamptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 178, doi. 10.1111/j.1749-6632.2000.tb07036.x
- By:
- Publication type:
- Article
Introduction.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. xi, doi. 10.1111/j.1749-6632.2000.tb07019.x
- By:
- Publication type:
- Article
Combined Radiation and 9-Nitrocamptothecin (Rubitecan) in the Treatment of Locally Advanced Pancreatic Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 320, doi. 10.1111/j.1749-6632.2000.tb07054.x
- By:
- Publication type:
- Article
Concluding Remarks.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 360, doi. 10.1111/j.1749-6632.2000.tb07065.x
- By:
- Publication type:
- Article
Preclinical and Phase I Clinical Studies with Ckd-602, a Novel Camptothecin Derivative.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 324, doi. 10.1111/j.1749-6632.2000.tb07055.x
- By:
- Publication type:
- Article
Ubiquitin, SUMO-1, and UCRP in Camptothecin Sensitivity and Resistance.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 306, doi. 10.1111/j.1749-6632.2000.tb07050.x
- By:
- Publication type:
- Article
The Combinatorial Synthesis of Racemic Homosilatecan Libraries via a Cascade Radical Annulation.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 317, doi. 10.1111/j.1749-6632.2000.tb07053.x
- By:
- Publication type:
- Article
Homocamptothecins: E-Ring Modified CPT Analogues.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 100, doi. 10.1111/j.1749-6632.2000.tb07029.x
- By:
- Publication type:
- Article
9-Nitrocamptothecin Liposome Aerosol Treatment of Human Cancer Subcutaneous Xenografts and Pulmonary Cancer Metastases in Mice.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 151, doi. 10.1111/j.1749-6632.2000.tb07033.x
- By:
- Publication type:
- Article
Structure-Activity Relationship of Alkyl Camptothecin Esters.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 122, doi. 10.1111/j.1749-6632.2000.tb07031.x
- By:
- Publication type:
- Article
Mechanisms of DNA Topoisomerase I-Induced Cell Killing in the Yeast: Saccharomyces cerevisiae.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 65, doi. 10.1111/j.1749-6632.2000.tb07026.x
- By:
- Publication type:
- Article
Topotecan (Hycamptin) and Topotecan-Containing Regimens in the Treatment of Hematologic Malignancies.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 247, doi. 10.1111/j.1749-6632.2000.tb07043.x
- By:
- Publication type:
- Article
Campthotecin Design and Delivery Approaches for Elevating Anti-Topoisomerase I Activities in Vivo.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 36, doi. 10.1111/j.1749-6632.2000.tb07023.x
- By:
- Publication type:
- Article
Camptothecins as Probes of the Microenvironments of Topoisomerase I - DNA Complexes.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 76, doi. 10.1111/j.1749-6632.2000.tb07027.x
- By:
- Publication type:
- Article
p53 and p21 Are Major Cellular Determinants for DNA Topoisomerase I-Mediated Radiation Sensitization in Mammalian Cells.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 298, doi. 10.1111/j.1749-6632.2000.tb07047.x
- By:
- Publication type:
- Article
Pharmacokinetics of Orally Administered Camptothecins.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 195, doi. 10.1111/j.1749-6632.2000.tb07038.x
- By:
- Publication type:
- Article
Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein: Potential Clinical Implications.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 188, doi. 10.1111/j.1749-6632.2000.tb07037.x
- By:
- Publication type:
- Article